Hs‐CRP is a marker of inflammation for CVD, which is consistent with Park, et al.'s study which found that patients with low irisin levels and hyperglycaemia were at an increased risk of metabolic syndrome and CVD. This evidence concerns the gene FNDC5 and metabolic syndrome.